Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Alix, Jacquier"'
Autor:
Joel LeMaoult, Nathalie Rouas-Freiss, Edgardo D. Carosella, Stephane Culine, François Desgrandchamps, Tzu-Min Hung, Ching-Lien Wu, Annabelle Goujon, Floriane Noel, Jerome Verine, Alix Jacquier, Clement Dumont
Upregulated and downregulated genes in CD8+ILT2+ T cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd7ba9da5adb490564457efc4cac075
https://doi.org/10.1158/2326-6066.22542484.v1
https://doi.org/10.1158/2326-6066.22542484.v1
Autor:
Joel LeMaoult, Nathalie Rouas-Freiss, Edgardo D. Carosella, Stephane Culine, François Desgrandchamps, Tzu-Min Hung, Ching-Lien Wu, Annabelle Goujon, Floriane Noel, Jerome Verine, Alix Jacquier, Clement Dumont
Control of non-presence of peripheral subpopulations among the tumor infiltrate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a62b8a385b53a8e660e8fcd2242768b
https://doi.org/10.1158/2326-6066.22542490.v1
https://doi.org/10.1158/2326-6066.22542490.v1
Autor:
Joel LeMaoult, Nathalie Rouas-Freiss, Edgardo D. Carosella, Stephane Culine, François Desgrandchamps, Tzu-Min Hung, Ching-Lien Wu, Annabelle Goujon, Floriane Noel, Jerome Verine, Alix Jacquier, Clement Dumont
Only some cancer patients respond to the immune-checkpoint inhibitors being used in the clinic, and other therapeutic targets are sought. Here, we investigated the HLA-G/ILT2 checkpoint in clear-cell renal-cell carcinoma (ccRCC) patients and focused
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8444b907470d03008659b479ef86d651
https://doi.org/10.1158/2326-6066.c.6549949
https://doi.org/10.1158/2326-6066.c.6549949
Autor:
Joel LeMaoult, Nathalie Rouas-Freiss, Edgardo D. Carosella, Stephane Culine, François Desgrandchamps, Tzu-Min Hung, Ching-Lien Wu, Annabelle Goujon, Floriane Noel, Jerome Verine, Alix Jacquier, Clement Dumont
ILT2 and HLA-G expression of THP1 and THP1-G1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60e0f8acdb208b45f43b929f4ff93459
https://doi.org/10.1158/2326-6066.22542493.v1
https://doi.org/10.1158/2326-6066.22542493.v1
Autor:
Joel LeMaoult, Nathalie Rouas-Freiss, Edgardo D. Carosella, Stephane Culine, François Desgrandchamps, Tzu-Min Hung, Ching-Lien Wu, Annabelle Goujon, Floriane Noel, Jerome Verine, Alix Jacquier, Clement Dumont
Key markers of CD8+ TILs of ccRCC patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1c3e9986e729887386f15218c6e02d
https://doi.org/10.1158/2326-6066.22542487
https://doi.org/10.1158/2326-6066.22542487
Autor:
Alix Jacquier, François Desgrandchamps, Jérôme Verine, Joel LeMaoult, Jean-François Delattre, Clement Dumont, Malika Djouadou, Edgardo D. Carosella, Nathalie Rouas-Freiss, Tiphaine Lambert
Publikováno v:
Cancer Letters. 519:105-116
HLA-G:ILT2 has recently been positioned as a major immune checkpoint in urologic cancers. In clear cell renal cell carcinoma (ccRCC), tumor-infiltrating CD8+ T cells expressing ILT2 are a highly cytotoxic cell population, distinct from PD1+ T cells,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79a6d88136ba58bd6ffcbd183d70d6ef
https://doi.org/10.1016/j.canlet.2021.06.018
https://doi.org/10.1016/j.canlet.2021.06.018
Autor:
Diana Tronik-Le Roux, Marina Daouya, Alix Jacquier, Chantal Schenowitz, François Desgrandchamps, Nathalie Rouas-Freiss, Edgardo D. Carosella
Publikováno v:
Cellular and Molecular Life Sciences. 79
The heterogeneity of cancer cells, in part maintained via the expression of multiple isoforms, introduces significant challenges in designing effective therapeutic approaches. In this regard, isoforms of the immune checkpoint HLA-G have been found in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec6fe6189a2a6ee058dff1cb86afc7e
https://doi.org/10.1007/s00018-022-04359-2
https://doi.org/10.1007/s00018-022-04359-2
Publikováno v:
Human Immunology. 81:168-177
HLA-G was described as a molecule inhibiting NK and T cells functions through its receptor, ILT2. However, most functional studies of HLA-G were so far performed on heterogeneous immune populations and regardless of ILT2 expression. This may lead to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ee1e508b1e0c5f6cd50ef4ced12f8b3
https://doi.org/10.1016/j.humimm.2020.02.001
https://doi.org/10.1016/j.humimm.2020.02.001
Autor:
Nathalie Rouas-Freiss, François Desgrandchamps, Tzu-Min Hung, Clement Dumont, Alix Jacquier, Edgardo D. Carosella, Jérôme Verine, Joel LeMaoult, Ching-Lien Wu, Annabelle Goujon, Stéphane Culine, Floriane Noel
Publikováno v:
Cancer Immunology Research. 7:1619-1632
Only some cancer patients respond to the immune-checkpoint inhibitors being used in the clinic, and other therapeutic targets are sought. Here, we investigated the HLA-G/ILT2 checkpoint in clear-cell renal-cell carcinoma (ccRCC) patients and focused
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fb7a3037d2d4c7815350904e15e1245
https://doi.org/10.1158/2326-6066.cir-18-0764
https://doi.org/10.1158/2326-6066.cir-18-0764
Autor:
Alix, Jacquier, Tiphaine, Lambert, Jean-François, Delattre, Malika, Djouadou, Jérôme, Vérine, Clément, Dumont, François, Desgrandchamps, Edgardo D, Carosella, Joel, LeMaoult, Nathalie, Rouas-Freiss
Publikováno v:
Cancer letters. 519
ILT2 has recently been positioned as a major immune checkpoint in urologic cancers. In clear cell renal cell carcinoma (ccRCC), tumor-infiltrating CD8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57d84ea92b191873e9def83c4d1883ed
https://pubmed.ncbi.nlm.nih.gov/34186161
https://pubmed.ncbi.nlm.nih.gov/34186161